In:
The Journal of Immunology, The American Association of Immunologists, Vol. 196, No. 1_Supplement ( 2016-05-01), p. 78.17-78.17
Abstract:
Staphylococcal enterotoxin B (SEB) is a bacterial protein capable of binding up to 20% of the entire T cell repertoire. T cells that have come into contact with SEB initially proliferate and secrete inflammatory cytokines; however, this is followed by anergy or death of the affected cells. This population of deleted or functionally inactivated cells is likely to include T cell clones that are important for immunity to other pathogens such as influenza A virus (IAV). For this reason, we hypothesize that SEB exposure will alter the magnitude and breadth of the CD8+ T cell response to IAV. Using mouse model of intraperitoneal vaccination with IAV, we found that prior exposure to SEB actually increased the number of IAV-specific CD8+ T cells for several IAV epitopes during the primary phase of the immune response. The number of cells specific for these epitopes remained elevated even after the peak of the primary CD8+ T cell response had passed. In addition, repetition of the first experiment with several different naturally circulating and lab-adapted strains of IAV gave similar results, showing that the effect of SEB on virus-specific CD8+ T cells is the same for a potentially diverse range of IAV strains. Furthermore, the ability of the CD8+ T cells to kill target cells pulsed with cognate IAV antigen was also enhanced after SEB exposure, for both primary and memory CD8+ T cells. Curiously, we did not observe an effect of SEB when it is given in the context of a replicative IAV infection in the lungs. This work reveals an unexpected role for SEB as an enhancer of CD8+ T cell immunity in this model.
Type of Medium:
Online Resource
ISSN:
0022-1767
,
1550-6606
DOI:
10.4049/jimmunol.196.Supp.78.17
Language:
English
Publisher:
The American Association of Immunologists
Publication Date:
2016
detail.hit.zdb_id:
1475085-5
Permalink
